Skip to main content
. Author manuscript; available in PMC: 2021 Aug 9.
Published in final edited form as: J Immunol. 2010 Dec 6;186(1):214–221. doi: 10.4049/jimmunol.1001172

table II.

Anti-Kd mAb recognition of H-2Kd on DST is necessary and sufficient to mediate skin allograft rejection in recipients treated with anti-CD154/DST

Group Graft DST Mean ± SEM
I. Kd .H-2bxk Kd .H-2bxk 11.5 ± 0.3 (N=6)
II. H-2bxk H-2bxk 60.0 ± 0.0 (N=6)
III. Kd .H-2bxk H-2bxk 52.3 ± 7.6 (N=6)
IV. H-2bxk Kd .H-2bxk 13.2 ± 0.4 (N=6)
V. H-2d 4X H-2d 11.5 ± 0.5 (N=4)